Hims & Hers Health (HIMS) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline
Hagens Berman announced a securities class action against Hims & Hers Health (HIMS) and certain executives, tied to the FTC's July 29, 2026 federal complaint also joined by Utah and Los Angeles County. The complaint alleges Hims shared sensitive consumer health data with third-party ad platforms including Meta and Snap, and billed customers before any medical consultation while imposing ROSCA-violating cancellation barriers. HIMS shares fell $4.32 (-14.7%) on the underlying news, erasing over $970 million in market cap; the lead plaintiff deadline is November 2, 2026.
Key figures
- Class period
- Aug. 4, 2025 - July 29, 2026
- Market cap erased
- $970 million
- Stock decline pct
- -14.7%
- Stock decline usd
- $4.32
- Lead plaintiff deadline
- Nov. 2, 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.